Welcome to our dedicated page for HEXO news (Ticker: HEXO), a resource for investors and traders seeking the latest updates and insights on HEXO stock.
HEXO Corp., formerly known as Hydropothecary, is a leading licensed producer and distributor of medical marijuana under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR). Dedicated to medical excellence, HEXO excels in advanced cultivation techniques, stringent process controls, quality assurance testing, ongoing research and development, and exceptional customer service.
With a focus on expanding its operations, HEXO is set to add a significant 250,000 square feet greenhouse in 2018 to meet growing demand. The company is constantly seeking talented, energetic, and specialized professionals to join its dynamic team and contribute to the rapidly evolving cannabis industry.
HEXO's product portfolio includes a wide range of medical cannabis products designed to meet the diverse needs of patients. The company is committed to innovation and quality, ensuring that all products meet the highest standards of safety and efficacy.
In recent news, HEXO Corp. has announced key partnerships and strategic initiatives aimed at bolstering its market position and expanding its product offerings. These include collaborations with leading organizations and the introduction of new, innovative products that cater to both the medical and recreational cannabis markets.
Financially, HEXO has shown remarkable growth, reflecting its strong market presence and operational efficiency. The company continues to invest in infrastructure and technology to support its long-term growth strategy and maintain its competitive edge in the industry.
For more information on HEXO Corp.'s latest developments, financial performance, and upcoming projects, visit our news section for the most updated data and insights.
HEXO Corp announced the successful closing of its underwritten public offering, generating total gross proceeds of US$144.8 million. The company sold 49,080,024 units at US$2.95 per unit, including a partial exercise of an over-allotment option. Each unit consists of one common share and half a warrant exercisable at US$3.45 for five years. The net proceeds will be utilized for the acquisition of Redecan and U.S. expansion. The offering was managed by A.G.P./Alliance Global Partners and Cantor Fitzgerald Canada Corporation.
HEXO Corp has officially completed its transfer of stock exchange listing from the New York Stock Exchange to the Nasdaq Capital Market, effective August 24, 2021. The transition will see HEXO’s common shares traded on Nasdaq, allowing current retail and institutional investors to retain their shares without any required action. HEXO, an award-winning cannabis producer, aims to enhance its market presence, targeting the top position in the Canadian recreational market post-acquisition of 48North and Redecan.
OTTAWA, Aug. 20, 2021 - HEXO Corp (TSX: HEXO; NYSE: HEXO) announced the pricing of its overnight marketed public offering of 47,457,628 Units at US$2.95 each, generating approximately US$140 million in gross proceeds. Each Unit consists of one common share and one half common share purchase warrant, with an exercise price of US$3.45. The funds will be utilized for the cash component of the Redecan acquisition and U.S. expansion plans. The Offering is subject to market conditions and expected to close on August 24, 2021.
HEXO Corp (TSX: HEXO; NYSE: HEXO) has announced its intent to file a preliminary prospectus supplement for an overnight marketed public offering of units. The offering's pricing and final terms are to be determined, with a potential additional 15% over-allotment option for underwriters. Proceeds will partially fund the Redecan acquisition and support HEXO's U.S. expansion plans. The offering is subject to market conditions and regulatory approvals.
HEXO Corp has appointed Valerie Malone as Chief Commercial Officer, effective September 6, 2021, aiming to strengthen its global leadership. Valerie brings over 20 years of experience from companies like PepsiCo and Whirlpool, and will oversee Marketing, Sales, and Product Development. This appointment is part of HEXO's strategy to enhance growth and improve earnings per share (EPS). Concurrently, the company announces the departure of Chief Development Officer James McMillan, who significantly contributed to HEXO's early success and partnerships.
HEXO Corp (TSX: HEXO; NYSE: HEXO) has announced its application to transfer its U.S. stock exchange listing from the New York Stock Exchange to Nasdaq, expected to be effective on August 23, 2021. The change aims to enhance shareholder value through cost savings and align HEXO with its industry peers on a prominent exchange. Existing shareholders will see their shares automatically transferred to Nasdaq, and no action is required on their part. Trading under the symbol 'HEXO' will continue on Nasdaq starting August 24, 2021.
HEXO Corp (TSX: HEXO; NYSE: HEXO) will participate in the Canaccord Genuity 41st Annual Growth Conference on August 10, 2021, at 1:00 p.m. ET. CEO Sebastien St-Louis and CFO Trent MacDonald will lead the presentation. Participants can access a live webcast on HEXO's Events page or directly at the Canaccord Webcast. HEXO is a licensed producer focusing on the Canadian cannabis market, aiming to be a leader in recreational market share with potential acquisitions.
HEXO Corp (TSX: HEXO; NYSE: HEXO) announced the upcoming filing of audited financial statements for its acquisition of Redecan, expected to close in Q3 2021. Redecan, Canada's largest privately-owned licensed producer, showcased impressive growth with a 146% revenue increase to $24.7M in Q1 FY21. The acquisition aims to solidify HEXO's market leadership in the cannabis sector, targeting a top-three position globally. CEO Sebastien St-Louis emphasized Redecan's strong consumer loyalty and operational efficiency, with a focus on achieving positive EPS in the future.
HEXO Corp (TSX: HEXO; NYSE: HEXO) has successfully closed its acquisition of a 50,000 sq. ft. production facility in Fort Collins, Colorado, marking its first US production site. This facility will enable HEXO to execute its strategy in the US market, providing access to its Powered by HEXO® technology. The site will also support the expansion of the joint venture with Molson Coors in creating CBD-infused beverages. This strategic move aims to enhance HEXO’s capacity for producing a wide range of cannabis products in compliance with local regulations.
FAQ
What is the market cap of HEXO (HEXO)?
What does HEXO Corp. do?
What recent expansion projects has HEXO undertaken?
What kind of products does HEXO offer?
Has HEXO announced any new partnerships?
What is HEXO's financial outlook?
Where can I find more information about HEXO's latest news?
What regulatory framework does HEXO operate under?
Is HEXO involved in research and development?
What is HEXO's commitment to quality?
How does HEXO contribute to the cannabis industry?
